Collectively, our integrated bioinformatics-experimental analyses results highlight the role of TINAGL1 as biomarker for distinguish lymph node metastatic lung SCC from benign tumors and the potential for ZNF334 as a generalizable gene to senescence bypass during lung squamous cell carcinoma progression to lymph nodes. The gene discussed is TINAGL1; the disease is benign neoplasm.